pHion Therapeutics and the Cell and Gene Therapy (CGT) Catapult today announce an exclusive licence agreement for pHion’s proprietary RALA technology.

October 3, 2017

Phion Therapeutics Ltd. announces a research program with Synpromics Ltd., one of the world's leading synthetic biology companies dedicated to finding ways to control gene expression and advancing the gene therapy opportunities of tomorrow.

Please reload

© 2019 by pHion Therapeutics Ltd.

  • Twitter - White Circle
  • Facebook - White Circle
  • LinkedIn - White Circle

pHion Therapeutics Ltd.

School of Pharmacy

Medical Biology Centre

97 Lisburn Road 



United Kingdom